Targeting human pathogenic bacteria by siderophores: A proteomics review

Area of Science:

• Microbiology and Infectious Diseases
• Proteomics and Biochemistry

Background:

• Bacterial infections pose a significant global health challenge, exacerbated by increasing antibiotic resistance.
• Pathogenic bacteria, particularly Gram-negative bacteria, rely on efficient iron acquisition systems, involving siderophores and their transporters, for survival and virulence within the human host.
• Traditional methods for identifying iron-scavenging molecules are being surpassed by more rapid and selective proteomic approaches.

Purpose of the Study:

• To review the critical role of siderophores in the virulence of human pathogenic Gram-negative bacteria.
• To discuss current and emerging proteomic strategies for identifying siderophore-related proteins and their expression levels.
• To highlight the potential of siderophores as antibiotics to combat drug resistance and the future integration of proteomics in clinical diagnostics.

Main Methods:

• Review of existing literature on bacterial iron acquisition, siderophore biology, and proteomic techniques.
• Analysis of proteomic strategies for identifying siderophore-related proteins and quantifying their expression under various growth conditions.
• Discussion of the application of siderophores in antibiotic development and the role of proteomics in clinical biomarker detection.

Main Results:

• Proteomic identification is a powerful, selective, and rapid method for discovering siderophore-related molecules compared to traditional biochemical and genetic screens.
• Siderophores are crucial for bacterial virulence and represent potential targets for therapeutic intervention.
• Proteomic tools are increasingly considered for standardization in the clinical detection of bacterial infectious disease biomarkers.

Conclusions:

• Understanding bacterial siderophore systems through advanced proteomic strategies is vital for combating infectious diseases and multidrug resistance.
• Siderophores hold promise as a new class of antibiotics, potentially utilizing a 'Trojan horse' mechanism to deliver antimicrobial agents.
• The integration of proteomics into routine clinical care is anticipated to significantly advance the diagnosis and management of bacterial infections.